Cambridge Healthtech Institute’s Inaugural

Oncolytic Virus Immunotherapy

Clinical Successes and Commercialization Strategies

20-21 March 2019

 

Oncolytic virotherapies have been emerging recently as potential in situ tumor vaccines with an attractive therapeutic combination of tumor-specific cell lysis together with patient-specific immune stimulation against cancer. The scientific community has continued to be impressed by the effectiveness and safety profile of these approaches which generates significant interest in this field. Cambridge Healthtech Institute’s Inaugural Oncolytic Virus Immunotherapy conference recognizes this active field and will bring together leading industry and academic leaders to discuss the critical steps needed to accelerate oncolytic virus immunotherapy into the clinic.

 

Coverage will include, but is not limited to:

 

  • Multiplex platform engineering
  • The role of metabolism in oncolytic virus therapy
  • Understanding mechanism of different oncolytic viruses and their interactions with the immune system
  • Advances in clinical trials of different virus constructs
  • Virus delivery strategies
  • Determining level of tumor infection required to treat cancer
  • The role of carrier cells in triggering immune responses
  • Combination therapy
  • Overcoming manufacturing challenges
  • Regulatory perspectives in Europe
  • Adoption, reimbursement and commercial delivery strategies

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is 10 September 2018.

 

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:
Emily Le

Conference Producer

Cambridge Healthtech Institute

Phone: (+1) 781-247-1812
Email: ele@healthtech.com

 

For partnering and sponsorship information, please contact:

Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-6286
Email: reymael@healthtech.com